Primary prevention of systemic lupus erythematosus.
In this Viewpoint, Drs Doria and Briani highlight recent advances in efforts to improve the long-term prognosis of patients with systemic lupus erythematosus. The strategies discussed aim to prevent both the occurrence of the disease and its complications.
Doria
Andrea
A
Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy. adoria@unipd.it
Briani
Chiara
C
D000974:Antibodies, Antinuclear / Q000097:blood; D017152:Antibodies, Antiphospholipid / Q000097:blood; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000276:immunology / Q000517:prevention & control*; D011322:Primary Prevention / Q000379:methods*; D013923:Thromboembolism / Q000517:prevention & control
D000974:Antibodies, Antinuclear; D017152:Antibodies, Antiphospholipid